Yasmin supplemental new drug application provides for new information of thromboembolism and vascular problems.
Bayer FDA Letter
© 2022 Law Office of Stephen H. Osborne, LTD. All rights reserved.
© 2022 Law Office of Stephen H. Osborne, LTD. All rights reserved.
Law firm websites by Market JD